Author:
Schoots Ivo G.,Heijmink Stijn W. T. P. J.,Zijta Frank M.,de Kok Bente M.,Quarles van Ufford Jet H. M. E.,Comans Emile F. I.,Baarslag Henk Jan
Reference14 articles.
1. Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate imaging – Reporting and data system: 2015, Version 2. Eur Urol. 2016;69:16–40.
2. Schoots IG, Bangma CH. MRI/US-fusion for targeted prostate biopsy. Ned Tijdschr Geneeskd. 2014;158:A7205.
3. Beresford MJ, Gillatt D, Benson RJ, et al. A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. Clinical oncology (Royal College of Radiologists (Great Britain)). 2010;22:46–55.
4. Gomez P, Manoharan M, Kim SS, et al. Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int. 2004;94:299–302.
5. Langsteger W, Haim S, Knauer M, et al. Imaging of bone metastases in prostate cancer: an update. The quarterly journal of nuclear medicine and molecular imaging: official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the So. 2012;56:447–58.